a numerical trendp = 0.333
Compared with IgAN patients, AAGN demonstrated significantly elevated uNAG levels (22.60 [14.00, 33.40] vs 14.40 [8.80, 22.10] U/gcr, p = 0.006), with a numerical trend toward higher uNGAL concentrations (29.30 [15.76, 45.14] vs 25.17 [13.52, 38.08] ng/mL, p = 0.333) and reduced urinary specific gravity (1.01 ± 0.01 vs. 1.02 ± 0.01, p = 0.132).